Yuyu Pharma

Yuyu Pharma, with the slogan "Great Hopes Make a Great Company," is a healthcare company founded in 1941 and publicly traded since 1975. Located in Korea, it focuses on manufacturing, distributing, and marketing pharmaceutical products, medical devices, and medical foods in South Korea and Southeast Asia. The company's key therapeutic markets include CNS, Osteoporosis, Respiratory, and Urology. Notably, its R&D center has developed two unique improved medicines, Maxmarvil® for patients with osteoporosis and YUCLID® for anti-thrombosis. Moreover, Yuyu Pharma is currently involved in two new drug discovery programs targeting benign prostatic hyperplasia (BPH) and dry eye syndrome. The company also offers Over-the-counter drugs and dietary supplements such as YupanC® (vitamin C), Venoplus® (ointment), and Venapollo® (multivitamins). With a strong stronghold in the Manufacturing and Pharmaceutical industries, Yuyu Pharma presents an intriguing investment opportunity for venture capitalists seeking exposure in the Asian healthcare market.